neuroprotection

Related by string. Neuroprotection * * *

Related by context. All words. (Click for frequent words.) 71 neuroprotective 67 immunomodulation 66 neuroprotective effects 66 pharmacologic 66 antiangiogenic 65 selective inhibition 65 neurotrophic 65 anti fibrotic 65 galanin 65 remyelination 64 CB2 receptor 64 neuro protective 64 pro angiogenic 64 neurotrophic factor 64 antitumor 64 mTOR inhibitors 63 cardioprotection 63 neurodegeneration 63 mGluR2 NAM 63 peroxisome proliferator activated 63 ischemia reperfusion injury 63 pharmacological 63 cytoprotective 63 glutamatergic 63 VEGF receptor 63 pathophysiology 63 receptor antagonists 63 NMDA receptor 63 neuroinflammatory diseases 63 renal fibrosis 63 AT1R 63 incretin 63 nNOS 63 neuronal nicotinic receptors NNRs 63 #beta HSD1 63 ACh 63 neuronal signaling 63 nitric oxide synthase 63 mGluR5 antagonist 62 vascular disrupting agents 62 mediated inhibition 62 PI3K/mTOR 62 pathogenic mechanisms 62 immune modulation 62 immunoregulatory 62 reperfusion injury 62 Th2 cytokines 62 IL 1ß 62 eNOS 62 resolvins 62 neuronal dysfunction 62 ERK1 2 62 mimetics 62 protein kinase C 62 vascular inflammation 62 VEGF inhibitors 62 synaptic function 62 axon regeneration 62 insulin sensitizing 62 vivo validation 62 PPARγ 62 neuroprotective properties 62 ZFP TF 62 hedgehog pathway 62 glucagon receptor 62 neurodegenerative diseases 62 glutamate receptors 62 immunomodulatory 62 P#X# 62 autophagic 62 dopaminergic 62 neurogenic 62 p# activation 62 anti angiogenic 62 histone deacetylase inhibitors 62 nicotinic acetylcholine receptor 62 cAMP signaling 62 hematopoiesis 62 Fc receptor 62 neurotrophic factors 62 therapeutic 61 beta adrenergic 61 immuno modulatory 61 ischemic preconditioning 61 prostaglandin synthesis 61 Inosine 61 antiapoptotic 61 ERK signaling 61 JAK3 61 GGF2 61 immunomodulatory effects 61 inhibiting COX 61 Factor VIIa 61 atherogenesis 61 leukotriene pathway 61 RANK Ligand 61 microglial activation 61 myocardial tissue 61 noradrenergic 61 antifibrotic 61 vidofludimus 61 enzyme inhibitors 61 mTOR 61 anti amnesic 61 CCR9 61 prodrugs 61 mTOR inhibition 61 receptor subtypes 61 calcineurin 61 antitumoral 61 TMEM#B 61 kinase pathway 61 Squalamine 61 glucocorticoid receptor 61 neuroprotective agent 61 cerebral ischemia 61 potent inhibitors 61 #ME# 61 inosine 61 uricase 61 ENaC 61 neurite outgrowth 61 p# inhibitor 61 hippocampal neurogenesis 61 renoprotective 61 COX2 61 ibudilast 61 potentiation 61 multitargeted 61 mechanistic insights 61 partial agonist 61 inhibit metastasis 61 lysosomal 61 neuronal nitric oxide synthase 61 signaling pathway 61 A3 adenosine receptor 61 Glucocorticoid 61 TGF ß 61 apoptotic pathway 61 cortical stimulation 61 renin angiotensin aldosterone 61 EGFR signaling 61 airway remodeling 61 Adenosine 61 CCR2 61 pathogenesis 61 rBChE 61 axonal damage 61 antisense oligonucleotide 61 neuroinflammation 60 beta 1a 60 vivo potency 60 nicotinic receptor 60 small molecule agonists 60 erythropoietic 60 immune modulating 60 CaM kinase II 60 Enkephalin 60 PlGF 60 lipoxygenase 60 IKK2 60 neovascularization 60 pharmacological inhibition 60 RANK ligand 60 cyclooxygenase 2 60 mineralocorticoid receptor 60 intracellular signaling pathways 60 Preclinical studies suggest 60 antisense inhibition 60 platelet activation 60 serotonergic 60 PEDF 60 p# MAPK 60 myocardial 60 bone morphogenetic proteins 60 neuroprotectant 60 nicotinic 60 p# pathway 60 neurotransmission 60 TRV# [001] 60 APOPTONE 60 gamma secretase inhibitor 60 chemokine receptor 60 Smad3 60 antibody mediated 60 peptide hormone 60 NRG1 60 lipoic acid 60 synaptogenesis 60 excitotoxic 60 Ataluren 60 ERK pathway 60 GRNCM1 60 5 HT2A receptor 60 mTOR mammalian target 60 JAK inhibitors 60 TGF β 60 natriuretic 60 receptor agonists 60 tranilast 60 sd rxRNA 60 γ secretase 60 Neuroinflammation 60 Wnt pathway 60 adult neurogenesis 60 UCP2 60 neuromuscular junction 60 axonal regeneration 60 cognitive enhancer 60 PI3K 60 Neuroprotection 60 biologic therapeutics 60 activated microglia 60 neuropsychiatric diseases 60 chemopreventive agent 60 mediated apoptosis 60 neuroinflammatory 60 cannabinoid receptor 60 SERCA2a 60 pharmacologic intervention 60 serotonin receptor 60 Interferon beta 60 Bendavia 60 SIRT1 60 HDAC inhibition 60 engineered RAP peptides 60 thromboxane A2 60 paricalcitol 60 effector function 60 siRNA therapeutics 60 LPA1 60 ligand TRAIL 60 small molecule activators 60 immune modulator 60 Neuropeptide Y 60 immunostimulatory effects 60 receptor antagonism 60 ischemia reperfusion 60 cardioprotective effects 60 norepinephrine reuptake inhibition 60 p#/CBP 60 neuronal plasticity 60 NADPH oxidase 60 Nav#.# 60 tumor suppressive 60 dexpramipexole 60 PI3 kinase 60 cMET 60 pharmacological chaperone 60 Hedgehog signaling 60 TGF beta1 60 Hedgehog signaling pathway 60 murine model 60 COX enzymes 60 IGFBP 3 60 antitumor effects 60 derived neurotrophic factor 60 oncomodulin 60 serine protease 60 pharmacodynamic endpoints 59 TRPV1 59 Synavive 59 NF kB pathway 59 endocannabinoid system 59 cardio protective 59 signaling pathways 59 eotaxin 59 TNFalpha 59 Hsp# inhibition 59 osteoclast formation 59 lung fibrosis 59 flavopiridol 59 Protein Kinase C 59 CG# [003] 59 peptibody 59 mTOR signaling 59 CB1 antagonists 59 Hedgehog pathway 59 growth hormone secretion 59 HDAC6 59 upregulate 59 tyrosine phosphorylation 59 BH4 59 Notch pathway 59 CDK inhibitor 59 peroxisomal 59 antiarrhythmic 59 inverse agonist 59 kidney urologic 59 PTHrP 59 chemopreventive 59 PPAR γ 59 plasma kallikrein 59 fibrinolytic 59 mTORC1 59 riociguat 59 NMDA antagonist 59 receptor subtype 59 nerve regeneration 59 Notch1 59 MAPK pathway 59 pathophysiological 59 HDAC inhibitors 59 GMX# 59 Orexin 59 fatty acid oxidation 59 fibrotic disease 59 Factor VEGF 59 Resten NG 59 MEK ERK 59 neuroregenerative 59 S#P# 59 fulvestrant 59 neurogenesis 59 neuronal function 59 experimentally induced 59 PDGFR 59 mTOR kinase 59 Factor NGF 59 NF kappaB activation 59 proapoptotic 59 pathophysiologic 59 nicotinic acetylcholine receptors 59 NMDA receptors 59 adenosine receptors 59 N methyl 59 osteogenic 59 TNF α 59 coagulation cascade 59 lung epithelium 59 adipogenic 59 HMG CoA reductase inhibitors 59 experimental autoimmune encephalomyelitis 59 demethylation 59 induce apoptosis 59 HuLuc# 59 allergic inflammation 59 PDE4 inhibitor 59 synapse formation 59 Akt activation 59 p# mitogen activated 59 myocyte 59 CGRP 59 #HT#A 59 RANKL 59 gamma secretase inhibitors 59 reversible inhibitor 59 tumor angiogenesis 59 poly ADP ribose polymerase 59 Hypoxia Inducible Factor 59 melanocortin receptors 59 preclinically 59 CEACAM1 59 nicotinamide 59 NTx TM -# 59 adrenoceptor 59 AMPA receptor 59 guanylate cyclase 59 interferon IFN 59 enkephalin 59 Hh pathway 59 glucose homeostasis 59 Aldosterone 59 Bevasiranib 59 mGluR4 59 tumor microenvironment 59 KL4 surfactant 59 direct thrombin inhibitors 59 erythropoiesis 59 Clusterin 59 histone deacetylases 59 vWF 59 SomatoKine 59 LPA1 receptor 59 muscarinic 59 intracoronary 59 PDE7 inhibitors 59 pharmacologic approaches 59 mechanistic insight 59 PPAR alpha 59 tumor vasculature 59 immune modulatory 59 ciliary neurotrophic factor 59 Kv#.# 59 upregulates 59 glucocorticoid 59 Desmoteplase 59 immunological 59 sphingolipid 59 PI3K pathway 59 hedgehog signaling 59 synaptic transmission 59 neurodegenerative 59 dopamine D1 59 Symadex 59 NNRs 59 GPR# [002] 59 thyroid hormone receptor 59 Brodmann Area 59 TNFa 59 cyclooxygenase 59 therapeutic interventions 59 adenosine receptor 59 tumorigenesis 59 neurodegenerative disorders 59 STAT3 58 investigational therapies 58 amyloid peptide 58 miR #a [001] 58 AMPAKINE 58 acetylcholinesterase AChE 58 aP2 58 pharmacologic agents 58 mGlu2 3 58 ENMD # 58 muscle contractility 58 HUCB cells 58 lymphangiogenesis 58 neuronal differentiation 58 tenascin C 58 PXD# 58 cannabinoid 58 vivo 58 TLR8 58 c myc gene 58 cannabinor 58 gastrointestinal motility 58 type glutamate receptor 58 vasodilatory 58 eicosanoid 58 NTDDS 58 selectively inhibiting 58 targeting PCSK9 58 epigenetic therapies 58 TNFα 58 Inhaled nitric oxide 58 selective modulator 58 lipid synthesis 58 VAPRISOL 58 ischemia induced 58 histone deacetylase 58 glucocorticoids 58 SERMs 58 SCD1 58 antiproliferative effects 58 NPD1 58 HIF 1alpha 58 cholinergic 58 gastrin 58 pan HDAC inhibitor 58 costimulatory 58 excitotoxicity 58 Endothelial 58 disease modifying 58 imexon 58 anticancer agent 58 motor neuron degeneration 58 proteoglycan 58 GABA neurotransmitter 58 cAMP 58 oxysterols 58 EP1 receptor 58 GRK2 58 Interferon alpha 58 PI3K inhibitor 58 neurturin 58 Bcl xL 58 prophylactic therapy 58 molecular mechanisms underlying 58 PI3K/AKT 58 PRT# 58 ADAMTS# 58 phosphate S1P 58 Syk 58 intranasal delivery 58 HPA axis 58 bFGF 58 transient receptor 58 HIF 1α 58 prostanoid 58 PLX cells 58 hypothalamic 58 VEGF 58 underlying pathophysiology 58 amyloid deposition 58 CTGF 58 PKC inhibitor 58 HIF 1a 58 adhesion molecule 58 ischemic 58 NFkappaB 58 FGFR1 58 somatostatin 58 neurotoxicity 58 orexin receptors 58 NF kB 58 CA4P 58 receptor PPAR 58 neurosteroid 58 Angiotensin II 58 HSP# inhibitors 58 Nrf2 58 Kinoid 58 signaling cascades 58 nAChR 58 Wnt signaling pathway 58 transgenic mouse model 58 ESBA# 58 p# MAP kinase 58 5 HT2C receptor 58 antiinflammatory 58 CXCR7 58 acadesine 58 PI3K inhibitors 58 IL 1beta 58 beta arrestin 58 Src kinase 58 CRAC channel 58 superoxide dismutase 58 benfotiamine 58 myogenesis 58 receptor gamma 58 transthyretin 58 pleiotropic effects 58 5 HT4 receptor 58 ubiquitin ligase 58 arterial thrombosis 58 matrix metalloproteinases 58 alagebrium 58 IL 1β 58 elastase 58 axonal degeneration 58 metabolic pathway 58 antithrombotic 58 mGluR 58 coronary vasodilation 58 hyperalgesia 58 nutlin 58 uPA 58 NK1 58 Prostacyclin 58 druggable target 58 HQK 58 endoplasmic reticulum stress 58 thrombolytics 58 TNF inhibitor 58 CCR9 antagonist 58 PDE1 58 NV1FGF 58 PTP 1B 58 mucociliary clearance 58 HDACi 58 TGF b 58 histone acetylation 58 TrkB 58 cyclophilin D 58 endothelial nitric oxide synthase 58 Smurf1 58 catabolism 58 PC# cells 58 Wnt signaling 58 activate p# 58 agonist 58 proteasome inhibition 58 tau phosphorylation 58 opioid analgesia 58 adult mesenchymal stem 58 SIRT1 gene 58 5 HT6 receptor 58 Aliskiren 58 molecular chaperones 58 factor Xa 58 phosphatidylinositol 3 58 dopaminergic neurons 58 melatonin receptor 58 HDAC 58 TNF alpha antagonist 58 deacetylase inhibitors 58 Eg5 58 galectin 3 58 inhibiting mTOR 58 mGluR2 58 glucocorticoid receptors 58 anti angiogenic agents 58 neuropeptide Y 58 Pimavanserin 58 peptide CGRP 58 miR #a [002] 58 c MET 58 Preclinical studies 58 HSP# inhibitor 58 LRP5 58 preclinical models 58 HCV replication 58 Neurogenesis 58 SYN# 58 protein kinase inhibitors 58 Posiphen 58 exon skipping 58 tumor hypoxia 58 S#A# [002] 58 IAP inhibitor 58 STAT3 signaling 58 hereditary emphysema 58 IGFBP2 58 organogenesis 58 ACE2 58 ApoA1 58 anticancer activity 58 mitogenic 58 bexarotene 58 Tβ4 58 chondrocyte 58 TGR5 58 endogenous opioid 58 small molecule inhibitors 58 proteasome inhibitor 58 Dysregulation 58 anticancer therapeutics 58 heme oxygenase 58 signal transduction 58 58 histone deacetylase HDAC 58 PARP inhibitors 58 blood clotting protein 58 potent anticancer 58 intracellular accumulation 58 selectively inhibits 57 PGE2 57 intracellular signaling 57 therapies 57 TGFβ 57 arginase 57 dissolving blood clots 57 Reverse Cholesterol Transport 57 antagomirs 57 N acetylcysteine 57 NF KB 57 serotonin reuptake 57 neovascular 57 Alpha lipoic acid 57 inhibitory neurotransmitters 57 PKCi 57 SGLT2 inhibitors 57 allopregnanolone 57 costimulation 57 NMDA N 57 neural degeneration 57 PKM2 57 hypometabolism 57 thrombin receptor 57 Tß4 57 tissue fibrosis 57 DNA demethylation 57 Pharmacokinetic studies 57 pathophysiological effects 57 coadministration 57 agonists 57 mitochondrial function 57 PPAR delta 57 synaptic plasticity 57 FKBP# 57 activin 57 BMP signaling 57 MGd 57 GSK3B 57 glomerular 57 FasL 57 induces apoptosis 57 cyclic adenosine monophosphate cAMP 57 VEGF inhibition 57 NNR Therapeutics 57 Davunetide 57 glutamate receptor 57 angiogenesis inhibitor 57 idraparinux 57 pharmacological interventions 57 LHRH antagonists 57 anti angiogenic drugs 57 inducible 57 pharmacological approaches 57 induced apoptosis 57 NF kB signaling 57 fosbretabulin 57 cilengitide 57 hypoxia inducible factor 57 angiogenesis inhibitors 57 molecular chaperone 57 thalidomide Thalomid 57 angiotensin receptor 57 S1P 57 novel peptide 57 BMAL1 57 therapeutic modality 57 targeted antifolate 57 ProSavin 57 RNAi therapeutic targeting 57 NF κB 57 VEGF pathway 57 intestinal absorption 57 TNF Tumor Necrosis Factor 57 enzymatic pathways 57 GRP# 57 Nanobody ® 57 radiosensitivity 57 vasodilator 57 CDK inhibitors 57 secreted protein 57 TLR3 57 L DOPA 57 clusterin 57 NF kappaB 57 heme oxygenase 1 57 VMAT2 57 Tasimelteon 57 prostaglandin D2 57 immunotoxins 57 anti CD3 57 Wnt beta catenin 57 TNF alpha inhibitor 57 estrogen receptor beta 57 aspirin clopidogrel 57 Teriflunomide 57 subtype selective 57 inflammatory cascade 57 CGEN # 57 NR2B 57 melatonin receptors 57 neurotrophins 57 acetylcholinesterase 57 interventional therapies 57 adrenomedullin 57 protein homeostasis 57 FBPase 57 osteoclast 57 PDGF receptor 57 hippocampal neurons 57 antidepressant efficacy 57 insulin sensitizers 57 tyrosine kinase inhibitor 57 Anti VEGF 57 rolipram 57 trial evaluating PRX# 57 phosphodiesterase inhibitors 57 retinal degeneration 57 OGG1 57 5 HT4 57 Panzem 57 TriRima 57 biased ligand 57 dexanabinol 57 isoform selective 57 NeuroTrans TM 57 ACV1 57 mitochondrial toxicity 57 CB1 receptor 57 proto oncogene 57 Cdc7 57 osteoblast differentiation 57 GABAA receptors 57 cytochrome P 57 antitumor efficacy 57 EGF receptor 57 neuronal apoptosis 57 c MYC 57 targeting CD# 57 NR2B subunit 57 RNase L 57 platelet inhibition 57 inhibitory 57 leukocyte recruitment 57 sd rxRNA compounds 57 SGLT2 57 osteoclast activity 57 PKC beta 57 inducible nitric oxide synthase 57 glial derived neurotrophic 57 lipid metabolism 57 VEGF induced 57 NKT cells 57 proteasome inhibitors 57 p# inhibitors 57 alpha#beta# 57 physiologic 57 cardiometabolic disorders 57 targeted radiotherapeutic 57 acetylcholine receptor 57 PPARg 57 upregulating 57 liposomal formulation 57 Akt signaling 57 C1 INH 57 Upregulation 57 anti angiogenesis 57 aldosterone antagonists 57 vascular disrupting agent 57 lymphotoxin 57 anti thrombotic 57 antiangiogenic agents 57 HSP# 57 cardiac contractility 57 Tumor Necrosis Factor 57 neurotransmitters serotonin 57 small molecule tyrosine 57 adipose derived stem cell 57 peripherally acting 57 potentiator 57 mitochondrial respiration 57 ERK activation 57 beta interferons 57 Cetrorelix 57 retinoid X 57 AKT inhibitor 57 EGFR HER 57 vaso occlusive crisis 57 reuptake inhibitor 57 striatal dopamine 57 airway hydration 57 Aurora Kinase 57 myogenic 57 osteoblast 57 vasodilatation 57 LSI #P 57 Histone deacetylase 57 Archexin 57 stem cell pluripotency 57 renin angiotensin system 57 kallikrein 57 receptor partial agonist 57 Enzastaurin 57 glial cell 57 Inhibition 57 thromboembolic disease 57 p# alpha [001] 57 demyelination 57 antisense oligonucleotides 57 cytokine 57 noninvasive imaging 57 Ischemic 57 Fenretinide 57 TrkA 57 PPARgamma 57 Valdoxan 57 innate immunity 57 pleiotropic 57 5 HT2A 57 selective agonist 57 mGluR4 activation 57 Dr. Fehlings 57 Fc fusion protein 57 NS5A 57 vascular permeability 57 57 cell transplantation 57 fatty acid synthase 57 Sgk1 57 receptor agonist 57 cellular pathways 57 VE cadherin 57 receptor blocker 57 losartan 57 anticancer therapy 57 Protein kinase 57 TGF beta signaling 57 cathepsins 57 NMDAR 57 intensive lipid lowering 57 apoE 57 telomerase activation 57 hepatic fibrosis 57 casein kinase 57 DFMO 57 hypothalamic pituitary adrenal axis 57 SIRT3 57 thymosin beta 4 57 receptor inhibitor 57 molecular pathway 57 Hsp# inhibitors 57 fondaparinux 57 microtubule targeting 57 CDDO Im 57 resolvin 57 β catenin 57 cyclic AMP 57 cardiac myocytes 57 secondary hyperparathyroidism 57 neuro degenerative diseases 57 Flt3 57 factor TNF 57 opioid antagonists 57 A2A receptor 57 preclinical efficacy 57 overactivation 57 pathophysiological mechanisms 57 cardiac hypertrophy 57 tumor suppressor protein 57 siRNA delivery 57 dopamine neuron 57 anti angiogenic therapies 57 CCX# 57 renin inhibitors 57 recombinant erythropoietin 57 plasma pharmacokinetics 57 Degarelix 57 humanised monoclonal antibody 57 pathological hallmarks 57 lipid lowering therapies 57 MAP kinase pathway 56 selectively inhibit 56 CCR3 56 metabolic enzymes 56 utrophin 56 Factor Receptor 56 cholesterol metabolism 56 antifolates 56 tumor suppressor 56 Sirt1 56 protein tyrosine phosphatase 56 XmAb# 56 visilizumab 56 Vascular Endothelial Growth 56 vasoactive 56 breast cancer metastasis 56 serine proteases 56 sGC 56 Nanobody 56 NMDA antagonists 56 5 lipoxygenase 56 kalirin 56 inhibit angiogenesis 56 LHRH agonists 56 protein CETP 56 TLR9 56 insulin sensitization 56 Oxidative damage 56 Endothelin 56 chemoprotective 56 CB1 receptors 56 androgen receptor AR 56 PPAR gamma 56 TRPV3 56 Signaling Pathway 56 muscular dystrophies 56 radioprotective 56 schizophrenia CIAS 56 treating neuropathic pain 56 selective inhibitors 56 ATL# [001] 56 endothelial activation 56 M1 muscarinic 56 mecamylamine 56 IKK beta 56 trophic factors 56 Aggrastat ® tirofiban hydrochloride 56 E selectin 56 Macrophage 56 mitogen activated protein kinase 56 bradykinin 56 Smoothened 56 cartilage regeneration 56 endogenous ligands 56 acinar cells 56 flecainide 56 thymidylate synthase TS 56 NKG2D 56 angiogenesis inhibition 56 CTAP# Capsules 56 olmesartan 56 siRNA therapeutic 56 apoE4 56 contractility 56 modulatory 56 anti atherogenic 56 mGluRs 56 bone metabolism 56 PAR1 56 protein tyrosine kinase 56 antisense compounds 56 PDE4 56 Angiotensin Converting Enzyme 56 potent inducer 56 VIPR2 56 antioxidant supplementation 56 vasodilators 56 prostacyclin receptor 56 tumor vascularization 56 cytokine interleukin 56 apelin 56 muscarinic receptors 56 hyperactivation 56 histone deacetylase inhibitor 56 vitro pharmacology 56 myo inositol 56 brain plasticity 56 bone morphogenetic protein 56 endothelial nitric oxide 56 immunotoxin 56 DITPA 56 HCV protease

Back to home page